ADM and myocardial infarction: In another study, a part of the ADM precursor peptide, mid-regional pro-adrenomedullin (MR-proADM), demonstrated a strong prognostic value for mortality and morbidity in patients with HF or LV dysfunction after an acute myocardial infarction [69].